High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.
Korean journal of ophthalmology : KJO（2016）
摘要
Increasing the dose of bevacizumab in refractory PED may be a possible treatment option.
更多查看译文
关键词
Age-related macular degeneration,Bevacizumab,Retinal pigment epithelial detachment,Vascular endothelial growth factor therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要